1. Home
  2. RBCAA vs PGEN Comparison

RBCAA vs PGEN Comparison

Compare RBCAA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$74.21

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.01

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBCAA
PGEN
Founded
1974
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
RBCAA
PGEN
Price
$74.21
$4.01
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
N/A
$8.33
AVG Volume (30 Days)
73.8K
5.4M
Earning Date
01-23-2026
05-13-2026
Dividend Yield
2.44%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$417,495,000.00
$230,981,000.00
Revenue This Year
$3.93
$1,115.92
Revenue Next Year
N/A
$81.04
P/E Ratio
$95.69
N/A
Revenue Growth
8.50
N/A
52 Week Low
$61.62
$1.23
52 Week High
$78.00
$5.47

Technical Indicators

Market Signals
Indicator
RBCAA
PGEN
Relative Strength Index (RSI) 64.91 53.07
Support Level $67.08 $3.31
Resistance Level $75.91 $4.44
Average True Range (ATR) 1.80 0.34
MACD 0.53 0.07
Stochastic Oscillator 83.45 71.43

Price Performance

Historical Comparison
RBCAA
PGEN

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: